How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

642 results for

Topical Preparations for the Scalp

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Topical steroids better than vitamin D for treating scalp psoriasis

Topical steroids better than vitamin D for treating scalp psoriasis Topical steroids better than vitamin D for treating scalp psoriasis Discover Portal Discover Portal Topical steroids better than vitamin D for treating scalp psoriasis Published on 14 June 2016 doi: Topical steroids applied to the scalp were more effective and safer for treating psoriasis than topical vitamin D alone. Using steroids in combination with vitamin D was statistically better than using a steroid alone (...) , but the difference was not considered clinically important. The combination ointment costs almost £20 for 30g compared to a 30g tube of typical steroid ointment which costs about £4. Scalp psoriasis is a common condition that can be itchy and embarrassing for many. A variety of topical lotions, solutions or gels are available to treat the condition, so this review of published research aimed to help doctors and patients find out which was the most effective and safest option. This systematic review found 59

2019 NIHR Dissemination Centre

2. Topical steroids better than vitamin D for treating scalp psoriasis

Topical steroids better than vitamin D for treating scalp psoriasis Topical steroids better than vitamin D for treating scalp psoriasis Discover Portal Discover Portal Topical steroids better than vitamin D for treating scalp psoriasis Published on 14 June 2016 doi: Topical steroids applied to the scalp were more effective and safer for treating psoriasis than topical vitamin D alone. Using steroids in combination with vitamin D was statistically better than using a steroid alone (...) , but the difference was not considered clinically important. The combination ointment costs almost £20 for 30g compared to a 30g tube of typical steroid ointment which costs about £4. Scalp psoriasis is a common condition that can be itchy and embarrassing for many. A variety of topical lotions, solutions or gels are available to treat the condition, so this review of published research aimed to help doctors and patients find out which was the most effective and safest option. This systematic review found 59

2018 NIHR Dissemination Centre

3. Topical Preparations for the Scalp

Topical Preparations for the Scalp Topical Preparations for the Scalp Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Topical (...) Preparations for the Scalp Topical Preparations for the Scalp Aka: Topical Preparations for the Scalp , Topical Foam , Mousse , Shampoo From Related Chapters II. Indications Preparation vehicles for medication delivery to the scalp and other hairy areas III. Advantages Easily applied (spread easily through hair surface) IV. Disadvantages Foams are more expensive than other Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Topical

2018 FP Notebook

4. Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02933502 Recruitment Status : Completed First Posted : October 14, 2016

2016 Clinical Trials

5. Topical Preparation Base

Preparation Base Aka: Topical Preparation Base , Preparation Bases From Related Chapters II. Approach ral Creams are most tolerable for all skin types (but less potent than ointments) Ointments Oily skin or hairy skin (including scalp) Gel, lotion or foam Sweaty skin (esp. intertriginous areas) Powders III. Preparations or Lesions on scalp or hairy areas or on oozy or wet lesions Jelly-like consistency that may be soothing to inflammatory lesions (e.g. ) Quick dries and does not cause hair matting Gels (...) Topical Preparation Base Topical Preparation Base Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Topical Preparation Base Topical

2018 FP Notebook

6. British Association of Dermatologists and British photodermatology Group guidelines for topical photodynamic therapy

licensed indications for the use of topical PDT in skin, hair and nail disorders. The clinical ef?cacy and appropriateness of other treatment modalities should also be considered, taking into account lesion site, histology, cosmesis, patient age and patient choice. All of the recommendations listed below apply where ser- vice provision makes them practically possible to do so. Preparation prior to photodynamic therapy R1 (GPP) Explain the potential bene?ts and harms of topical PDT to the patient (...) and provide a BAD patient information lea?et (www.bad.org.uk/leaflets) for PDT before choosing the treatment. R2 (GPP) Refer to the appropriate summaries of product characteristics on the electronic Medicines Compendium when administering PDT, as there are different preparation and administration procedures for each licensed indication. Basal cell carcinoma R3 ( ) Offer* topical PDT as a treatment option to people with super?cial BCC, particularly for poorly healing or cos- metically sensitive skin sites

2019 British Association of Dermatologists

7. Betamethasone for Adults with Scalp Psoriasis

Betamethasone for Adults with Scalp Psoriasis Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. Rapid responses should be considered along with other types (...) difficulty applying topical treatments. 2,3 In addition, many patients find both the symptoms of scalp psoriasis itself, including itching, burning, and pain, and treatment distressing given the visibility of the scalp, and scalp psoriasis is associated with a reduced quality of life. 1,2 The visibility of the scalp and the reduced quality of life associated with scalp psoriasis highlight a need for treatments that are both effective and do not have a negative impact on appearance. Topical treatment

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

8. Topical Preparations for the Scalp

Topical Preparations for the Scalp Topical Preparations for the Scalp Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Topical (...) Preparations for the Scalp Topical Preparations for the Scalp Aka: Topical Preparations for the Scalp , Topical Foam , Mousse , Shampoo From Related Chapters II. Indications Preparation vehicles for medication delivery to the scalp and other hairy areas III. Advantages Easily applied (spread easily through hair surface) IV. Disadvantages Foams are more expensive than other Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Topical

2015 FP Notebook

9. Atopic Dermatitis - Guidelines for Prescribing Topical Corticosteroids

will sting/irritate open areas of eczema Gel Less greasy, good for hairy areas, oily skin Alcohol base will sting/irritate open areas of eczema Ointment Excellent penetration, offers emollient effect, little or no irritation, good for very dry, scaly areas Cosmetically less acceptable, thick, greasy Scalp Lotion Superior for scalp involvement Alcohol base will sting/irritate open areas of eczema Dose of topical can be described in fingertip units (FTU). One FTU is the amount squeezed out from a standard (...) lowest effective potency over smallest skin area for shortest duration needed to control symptoms. Lactation: It is considered unlikely that application of topical corticosteroids applied by the mother would be passed to the infant via breastmilk. If a corticosteroid preparation is being applied to the breast, it should be carefully wiped off before breastfeeding. Preventing recurrences Continue with optimal skin care with emollients and moisturizers If, despite optimal skin care, there are frequent

Full Text available with Trip Pro

2017 medSask

10. Tinea Cruris Skin Infection - Guidelines for Prescribing Topical Antifungals

Tinea Cruris Skin Infection - Guidelines for Prescribing Topical Antifungals Tinea Cruris Skin Infection - Guidelines for Prescribing Topical Antifungals - medSask Home - College of Pharmacy and Nutrition - University of Saskatchewan Toggle Menu Search the U of S Search Tinea Cruris Skin Infection - Guidelines for Prescribing Topical Antifungals Fungal or tinea infections of the skin are common, with tinea corporis (ringworm) and tinea cruris (jock itch) affecting 10 to 20% of the general (...) Reddened areas can extend down inner leg or upwards to stomach or buttocks Edges are bumpy or scaling Burning and itching are common Often co-morbid with tinea pedis and tinea unguium (toe-nail infection) Rule out the following conditions which can resemble tinea cruris: (candida intertrigo) - yeast infection which covers penis and scrotum as well as groin area with diffuse, red papular lesions. This may be treated with OTC antifungals - appears as yellow, greasy, scales on scalp and may extend down

2017 medSask

11. Tinea Corporis Infection - Guidelines for Prescribing Topical Antifungals

to 10 cm in circumference Itchiness and burning sensation are common, but may be asymptomatic Outbreaks common in close-contact sports Rule out the following conditions which can resemble tinea corporis. With the exception of seborrheic dematitis, these conditions do not respond to topical antifungal treatment. Bacterial infections such as - pustules with honey-colored crusts or fluid-filled blisters. - appears as yellow, greasy, scales on scalp and may extend down to face and upper chest (...) most commonly on face but can also occur on the chest and back. Refer to patient's primary care provider - may resemble ringworm without scales at the site of a tick bite. It has a typical bull's-eye appearance starting around the bite and spreading outward. Refer to patient's primary care provider - infection of the scalp involving skin surrounding the hair shaft. It is most common in children and if left untreated, can cause scarring and permanent hair loss. Topical treatment does not work

2017 medSask

12. Tinea Pedis Infection - Guidelines for Prescribing Topical Antifungals

Tinea Pedis Infection - Guidelines for Prescribing Topical Antifungals Tinea Pedis Infection - Guidelines for Prescribing Topical Antifungals - medSask Home - College of Pharmacy and Nutrition - University of Saskatchewan Toggle Menu Search the U of S Search Tinea Pedis Infection - Guidelines for Prescribing Topical Antifungals Fungal or tinea infections of the skin are common. Tinea pedis (athlete’s foot) has an incidence of up to 50% of the general population. More common in men and teenagers (...) or shoes (e.g. latex). Refer to Guideline for Atopic Dermatitis - yeast infection between the toes - moist, white peeling skin. This can be treated with OTC antifungals - appears as yellow, greasy, scales on scalp and may extend down to face and upper chest in the form of circular scaly pink patches. In some cases can also affect areas between the toes. May respond to self-care treatment. More severe cases should be referred to the patient's primary care provider – discrete, focused callus

2017 medSask

13. Mycoster (ciclopirox) - seborrhoeic dermatitis of the scalp

Mycoster (ciclopirox) - seborrhoeic dermatitis of the scalp HAS - Medical, Economic and Public Health Assessment Division 1/23 The legally binding text is the original French version T TR RA AN NS SP PA AR RE EN NC CY Y C CO OM MM MI IT TT TE EE E Opinion 18 December 2013 MYCOSTER 10 mg/g, shampoo B/1 bottle of 60 ml (CIP: 34 009 368 640 0 9) Applicant: PIERRE FABRE DERMATOLOGIE INN ciclopirox ATC code (2012) D01AE14 (Antifungals for topical use) Reason for the request Inclusion Lists concerned (...) National Health Insurance (French Social Security Code L.162-17) Hospital use (French Public Health Code L.5123-2) Indications concerned “Treatment of seborrhoeic dermatitis of the scalp.” HAS - Medical, Economic and Public Health Assessment Division 2/23 Actual Benefit Moderate Improvement in Actual Benefit MYCOSTER 10 mg/g shampoo provides no improvement in actual benefit (level V, non-existent) in comparison with other topical antifungals (KETODERM 2% sachets, SEBIPROX 1.5% shampoo) used

2014 Haute Autorite de sante

14. Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis

A, methotrexate, azathioprine, mycophenolate mofetil, fumaric acid esters, retinoids, JAK inhibitors, corticosteroids, any other experimental drug, etc. Topical medications (eg. Corticosteroids) except coal tar shampoo, and/or salicylic acid scalp preparations on scalp lesions. 4 weeks for phototherapy (ie, UVB, PUVA). Infection(s) requiring treatment with intravenous (IV) anti-infectives within 30 days prior to the Baseline visit or oral anti-infectives within 14 days prior to the Baseline visit; Positive (...) Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Apremilast

2018 Clinical Trials

15. Insect Bites - Guidelines for Prescribing Topical Hydrocortisone

Insect Bites - Guidelines for Prescribing Topical Hydrocortisone Insect Bites - Guidelines for Prescribing Topical Hydrocortisone - medSask Home - College of Pharmacy and Nutrition - University of Saskatchewan Toggle Menu Search the U of S Search Insect Bites - Guidelines for Prescribing Topical Hydrocortisone Insect bites which cause local inflammatory reactions are puncture wounds from insects whose saliva contains concentrated irritant substances such as anticoagulants and enzymes. Symptoms (...) produce some decrease in itch and inflammation. Apply 1 to 2 times daily for up to one week. Menthol-containing products or ammonia-containing products help cool the area to reduce pain and itch. Anyone who has had a systemic reaction to a bite or sting should carry an epinephrine injector device. Options not recommended: Calamine creams and lotions may help soothe, but the dried residue may exacerbate the itch in some people. Topical antihistamines may cause sensitization. It is unlikely

2016 medSask

16. Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland

was the calcipotriol and betamethasone dipropionate gel (Xamiol). The comparators were standard topical treatments, including calcipotriol scalp solution, coal tar preparations, and potent or very potent topical steroids. Twelve treatment pathways were modelled: two had the gel as a first treatment; two had it as the second option; three had it as the third option; and five were variations of usual care. The average of these five variations was used for the usual practice in Scotland. Location/setting Scotland/out (...) -patient care. Methods Analytical approach: A Markov model was developed to estimate the benefits and costs of the treatment options, over one year, for a cohort of adults aged 18 years or older, with moderately severe scalp psoriasis, that had not been cured by shampoos, emollients, or both. The authors stated that the perspective was that of the Scottish NHS. Effectiveness data: The clinical effectiveness measure was the ability of topical treatments to control disease at four weeks. Patients were

2011 NHS Economic Evaluation Database.

17. Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

Pharmaceuticals, Inc. Information provided by (Responsible Party): DUSA Pharmaceuticals, Inc. Study Details Study Description Go to Brief Summary: The purpose of this study is to prove the safety and efficacy of Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution 20% followed by 10 J/cm2 of blue light delivered at 10 mW/cm2 or 20 mW/cm2 in the treatment of multiple actinic keratosis on the face or balding scalp (the Treatment Area), utilizing a 14-18 hour incubation period. Condition or disease (...) (AMINOLEVULINIC ACID HCl) FOR TOPICAL SOLUTION, 20% AND 10 J/CM2 OF BLUE LIGHT DELIVERED AT 10 MW/CM2 OR 20 MW/CM2 BY A NEW LIGHT SOURCE FOR THE TREATMENT OF ACTINIC KERATOSES ON THE FACE OR SCALP Estimated Study Start Date : March 2017 Estimated Primary Completion Date : September 2017 Estimated Study Completion Date : January 2018 Resource links provided by the National Library of Medicine available for: resources: Arms and Interventions Go to Arm Intervention/treatment Experimental: ALA 20 mW ALA + IBL 10J

2017 Clinical Trials

18. Concomitant Limb Cryocompression and Scalp Cooling to Reduce Paclitaxel-induced Neuropathy and Alopecia

therapy. Masking: None (Open Label) Primary Purpose: Prevention Official Title: Concomitant Limb Cryocompression and Scalp Cooling to Reduce Paclitaxel-induced Neuropathy and Alopecia Actual Study Start Date : August 4, 2017 Estimated Primary Completion Date : August 31, 2019 Estimated Study Completion Date : April 30, 2020 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Healthy subjects (...) Concomitant Limb Cryocompression and Scalp Cooling to Reduce Paclitaxel-induced Neuropathy and Alopecia Concomitant Limb Cryocompression and Scalp Cooling to Reduce Paclitaxel-induced Neuropathy and Alopecia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2017 Clinical Trials

19. Fungal skin infection - scalp

is uncertain. Treatment in primary care is unsuccessful. There is a suspected complication which is not responding to treatment in primary care. If a person is a known contact of a person with confirmed fungal scalp infection: Skin and hair sampling for fungal culture should be arranged to determine if the contact has confirmed infection or is an asymptomatic carrier. Have I got the right topic? Have I got the right topic? From age 1 month onwards. This CKS topic covers the diagnosis and management (...) of fungal infection of the scalp (tinea capitis), and the management of contacts. This CKS topic does not cover the diagnosis and management of other fungal infections of the skin and nails. There are separate CKS topics on , , , and . The target audience for this CKS topic is healthcare professionals working within the NHS in the UK, and providing first contact or primary healthcare. How up-to-date is this topic? How up-to-date is this topic? Changes Changes March to April 2018 — reviewed. A literature

2014 NICE Clinical Knowledge Summaries

20. Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

of atopic dermatitis condition (e.g., tumor necrosis factor [TNF] inhibitors, anti- immunoglobulin [Ig]E antibodies, anti-CD20 antibodies, anti-interleukin [IL]-4 receptor). From 28 days prior to the first application of study drug until the completion of the Follow- up visit or discontinuation: Corticosteroid preparations (oral, injection, and suppository preparations) and topical corticosteroids that were classified as super-high potency (clobetasol propionate). Eye drop and nasal preparations (...) to the completion of the Follow-up visit or discontinuation: Herbal medicines for atopic dermatitis (topical and oral preparations), unless specifically approved by the sponsor; Eucrisa™ (crisaborole) and any other topical phosphodiesterase 4 (PDE4) inhibitor; Tacrolimus and pimecrolimus cream and/or ointment; Topical corticosteroids that were classified as low, medium, or high potency (fluocinonide, triamcinolone acetonide, desonide, hydrocortisone). Eye drops and nasal preparations are allowed. From 7 days

2017 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>